We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Genedrive Plc | LSE:GDR | London | Ordinary Share | GB00B1VKB244 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.025 | 1.56% | 1.625 | 1.60 | 1.65 | 1.675 | 1.60 | 1.60 | 11,401,604 | 10:40:03 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 55k | -5.15M | -0.0447 | -0.36 | 1.87M |
Date | Subject | Author | Discuss |
---|---|---|---|
25/1/2021 08:22 | 10,000 share buyer looks to be wanting plenty | bunz3 | |
25/1/2021 08:18 | strong start for covid testing shares | bunz3 | |
25/1/2021 08:14 | Go and buy syme | matunde24 | |
25/1/2021 08:05 | nice start to Today again | bunz3 | |
25/1/2021 08:03 | buying building again Today | bunz3 | |
25/1/2021 01:21 | might this be part of reason for the chunky buys on Friday | bunz3 | |
25/1/2021 01:20 | might this be part of reason for the chunky buys on Friday | bunz3 | |
25/1/2021 00:55 | Fridays blue day so many large buys is rerate on the way ,when that number of chunky buys seen here Yesterday covid testing going to be in demand for some time to come | bunz3 | |
25/1/2021 00:55 | is this part of reason why so much buying and blue day testerday are the chunky buyers thinking is it time to load up Point-of-Care solution to detect SARS-CoV-2 virus ,22nd October rns like this part of it The Genedrive SARS-CoV-2 POC Kit follows a similar workflow that has already been validated in the Company's Genedrive® HCV-ID Kit which received WHO pre-qualification earlier this year. The Company is targeting the end of the calendar year for completion of preliminary product evaluations, with full release of the final CE Marked system in Q1 2021 allowing for thorough clinical testing requirements. Additionally, the Company is working to progress to a version 2 of the product, which would accept a similar freeze-dried PCR bead format previously developed for the high throughput Genedrive® 96 SARS-CoV-2 Kit. This will allow for lower production costs and highly scalable manufacturing capacity. | bunz3 | |
24/1/2021 19:52 | News this week. Set your alarms each morning. | hodhasharon | |
24/1/2021 08:03 | Hods mum died with covid.Rip aunty zainab. | professor_davepicklestower | |
23/1/2021 13:04 | is this part of reason why so much buying and blue day testerday are the chunky buyers thinking is it time to load up Point-of-Care solution to detect SARS-CoV-2 virus ,22nd October rns like this part of it The Genedrive SARS-CoV-2 POC Kit follows a similar workflow that has already been validated in the Company's Genedrive® HCV-ID Kit which received WHO pre-qualification earlier this year. The Company is targeting the end of the calendar year for completion of preliminary product evaluations, with full release of the final CE Marked system in Q1 2021 allowing for thorough clinical testing requirements. Additionally, the Company is working to progress to a version 2 of the product, which would accept a similar freeze-dried PCR bead format previously developed for the high throughput Genedrive® 96 SARS-CoV-2 Kit. This will allow for lower production costs and highly scalable manufacturing capacity. | bunz3 | |
23/1/2021 13:02 | The Company is targeting the end of the calendar year for completion of preliminary product evaluations, with full release of the final CE Marked system in Q1 2021 allowing for thorough clinical testing requirements | bunz3 | |
23/1/2021 13:01 | is this part of reason why so much buying and blue day testerday are the chunky buyers thinking is it time to load up Point-of-Care solution to detect SARS-CoV-2 virus ,22nd October rns like this part of it The Genedrive SARS-CoV-2 POC Kit follows a similar workflow that has already been validated in the Company's Genedrive® HCV-ID Kit which received WHO pre-qualification earlier this year. The Company is targeting the end of the calendar year for completion of preliminary product evaluations, with full release of the final CE Marked system in Q1 2021 allowing for thorough clinical testing requirements. Additionally, the Company is working to progress to a version 2 of the product, which would accept a similar freeze-dried PCR bead format previously developed for the high throughput Genedrive® 96 SARS-CoV-2 Kit. This will allow for lower production costs and highly scalable manufacturing capacity. | bunz3 | |
23/1/2021 12:59 | It could double or triple in no time of news about sales is proved. | losses | |
23/1/2021 11:36 | yesterdays blue day so many large buys is rerate on the way ,when that number of chunky buys seen here Yesterday covid testing going to be in demand for some time to come | bunz3 | |
23/1/2021 11:18 | Bunz, destroy this. Remeber what Hod did in syme | professor_zxie | |
23/1/2021 11:00 | will 50p be seen next week if these buyers now back loading up at this share | bunz3 | |
23/1/2021 10:30 | WHY were the larger buyers loading up here yesterday why would they have returned to gdr www.pharmiweb.com/pr | bunz3 | |
23/1/2021 10:26 | so many buyers returned yesterday who ever the larger buyers investing the money here are they thinking is news close | bunz3 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions